Stakeholder perceptions of what makes a care home homely

Stakeholder perceptions of what makes a care home homely

EMAS2017 / Maturitas 100 (2017) 93–202 O26 Stakeholder perceptions of what makes a care home homely Anne Fleming 1,∗ , Angela Kydd 2 , Sally Stewart ...

64KB Sizes 0 Downloads 15 Views

EMAS2017 / Maturitas 100 (2017) 93–202

O26 Stakeholder perceptions of what makes a care home homely Anne Fleming 1,∗ , Angela Kydd 2 , Sally Stewart 3 1

None, Glasgow, United Kingdom Edinburgh Napier University, Edinburgh, United Kingdom 3 Glasgow School of Art, Glasgow, United Kingdom 2

Background: This doctoral study explored the concept of homeliness as perceived by residents, relatives and staff of Scottish care homes for older people. Following ethical approval from the West of Scotland Research Ethics Committee seven relatives, five residents and four staff participated in the study. Aims: To explore the concept of creating a home like environment and whether a ‘homely’ care home is a priority in the expressed needs and wishes of residents, staff and the relatives who visit care homes. Methods: A mixed methodology design was selected using both an observational environmental assessment tool and Q methodology. The literature review concluded that homeliness was a complex concept, which was highly individual, and this information used to inform the first interviews with the participants. These interviews were then thematically analysed and mapped against the literature. Statements representing each theme were developed and 30 formed the Q-set. A pilot study concluded that the concourse was adequately represented by these 30 statements. Findings: Three factors were extracted from analysis of the completed Q-sorts. Relatives and staff loaded on Factor 1 (Standards Driven) while Factors 2 (Making the Most of It) and 3 (A Sense of Belonging) were representative of residents, staff and relatives. By mapping these factors onto Maslow’s Hierarchy of Need it could be seen that these Factors could be related to the journey that individuals make when moving from home to the care home. Conclusion: The results suggested that meeting the standards of care required by the inspection bodies was of importance, but not enough to engender a feeling of homeliness. O27 Skeletal muscle and vitamin D level in women of various ages Vladyslav Povoroznyuk ∗ , Nataliia Dzerovych, Tetiana Solonenko, Olena Vdovina D.F. Chebotarev Institute of Gerontology NAMS Ukraine, Kyiv, Ukraine Introduction: In recent years there has been a number of studies examining the correlation between vitamin D status and skeletal muscles. However, there are many different approaches to the role of vitamin D metabolism and function of skeletal muscles. The aim of the research conducted at the SI «D.F. Chebotarev Institute of Gerontology NAMS of Ukraine» was to study the correlation between skeletal muscles and vitamin D level in women of different ages. Materials and methods: The study involved 122 healthy women aged 20 to 83 years. According to the gerontological classification, the examined women were divided into groups: younger – up to 44 years (n = 35), middle – 45–59 years old (n = 26), older – 60–74 years (n = 44), senile age – 75–89 years (n = 17). Lean mass of the total body, upper and lower extremities was evaluated using Dual X-ray absorptiometry (Prodigy, GEHC Lunar, Madison,


WI, USA). Strength of skeletal muscle was evaluated using springy carpal dynamometer. To determine the functional capacity of skeletal muscle we used a «four-meter» test. To determine the level of 25(OH)D electrochemiluminescent method was used with Elecsys 2010 analyzer (Roche Diagnostics, Germany). Results: We determined a significant correlation between parameters of lean mass (r = 0.45; t = 2.08; p = 0.05) and the level of vitamin D in women of middle (45–59 years) age; skeletal muscle functionality (r = −0.51; t = −2.29; p = 0.04) and the level of vitamin D in women of older (60–74 years) age. We did not find the significant correlation between parameters of muscle strength and level of vitamin D. Conclusion: Significant correlation between parameters of lean mass, skeletal muscle functionality and the level of vitamin D was determined in women of middle and older age. Oral Communications 5 O28 Metabolic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in ob/ob mice Christin Moser 1 , Steve Vickers 2 , Richard Brammer 2 , Sharon Cheetham 2 , Matthias Unger 1 , Jürgen Drewe 1,∗ 1 2

MaxZeller Söhne AG, Romanshorn, Switzerland RenaSci Ltd, Nottingham, United Kingdom

Metabolic changes have been often described in perimenopausal women. Therefore, the present experiments evaluated the potential antidiabetic effects of the Cimicifuga racemosa extract Ze 450. Ze 450 and some of its components (23-epi-26-deoxyactein, protopine and cimiracemoside C) were investigated in vitro for their effects on AMP-activated protein kinase (AMPK) compared to metformin in HepaRG cells. Ze 450 (given orally (PO) and intraperitonally (IP)), metformin (PO) and controls were given over 7 days to 68 male ob/ob mice. Glucose and insulin concentrations were measured at baseline and during an oral glucose tolerance test (OGTT). Ze 450 and its components activated AMPK to the same extent as metformin. In mice, Ze 450 (PO/IP) decreased significantly average daily and cumulative weight gain, and daily food and water intake, while metformin had no effect. In contrast to metformin, PO Ze 450 virtually did not change maximum glucose levels during OGTT, but, prolonged elimination. Ze 450 administered PO and IP decreased significantly glucose-stimulated insulin, whereas metformin did not. HOMA-IR index of insulin resistance improved significantly after IP and PO Ze 450 but only slightly after metformin. In summary, the results demonstrate that Ze 450 reduced significantly body weight, plasma glucose, improved glucose metabolism and insulin sensitivity in diabetic ob/ob mice. In vitro experiments suggest that part of the effects may be related to AMPK activation. Therefore, Ze 450 may have utility in the treatment of type 2 diabetes. Thus, Ze 450 given for the treatment of menopausal symptoms in perimenopausal women may give an additional benefit. However, longer term studies in additional animal models or patients with disturbed glucose tolerance or type II diabetes may be of use to further investigate this hypothesis.